Tagged with EY

Puerto Rico Jose Viera-Colon, Region Director Caribbean for Allergan, highlights the opportunities and obstacles related to leading the company’s commercial operations in Puerto Rico and countries like the Dominican Republic. He also gives insights in planned product launches in CNS and eyecare and explains Allergan’s approach to ensure product affordability for Puerto…

China Jin Wang, Partner and Co-leader of the McKinsey China Healthcare Practice, shares the wide-ranging scope of her focus on ‘Big Healthcare’ involving work with healthcare service providers and payers, and pharmaceutical and medical products; the holistic and impactful solutions McKinsey can offer to the complex problems their clients face; as well…

China China’s pharma market is growing at an unprecedented pace and has become a key element of virtually all pharma multinationals’ international strategies. However, with a spate of regulatory reforms being rolled out, it can be challenging for large organizations with headquarters located in slower-paced mature markets to adapt to China’s…

China Gaobo Zhou is Partner and co-leader of the Healthcare Practice in China and has been with McKinsey for over a decade, Gaobo discusses the changes occurring within the complex and fast-paced Chinese healthcare landscape over the past few years and how McKinsey supports industry stakeholders in China to help them…

Turkey Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the evolving profiles she looks for when hiring country managers for healthcare and the life sciences companies in the dynamic Turkish market.   What are the qualities you look for in a Country Manager?…

France Martine Claret of Horus Pharma – a family-owned ophthalmology pharmaceutical company established in 2003 and based in Nice – discusses the highly regulated and competitive ophthalmology market, the company’s remarkable recent growth, and the state of play for SMEs in France today.   We as a flexible medium-sized company have…

Turkey Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its neighbours – stands as one of the most promising healthcare and life science investment destinations in its region. Topics covered in this report range from the successes…

Turkey Imports and exports in Turkish pharma between 2010 and 2017. Pharmaceutical exports grew to a total of USD 898 million in 2017.   These charts show both the volume and value of imported and locally-produced drugs in the Turkish pharma market between 2010 and 2017. TL 13.33 billion (USD 2.57…

Turkey Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on hospital investment.   Throughout many of the healthcare systems in North America and Europe, there is an increasing emphasis on outpatient and preventative care. In terms of health economics, governments see a great benefit in…

Turkey Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the strategic importance of the chemical and pharmaceutical sectors in Turkey’s exports. He underscores pharma’s role in Turkey’s ‘Vision 2023’ and explains how IMMIB is helping the sector increase its export potential.   With our 29…

Turkey Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has implemented in Turkey and its successes, provides insights into future collaborations and discusses the importance of a holistic approach focusing on preventive technologies.   Having a holistic approach across healthy living, prevention, diagnostic,…

Turkey Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city hospitals project, highlighting the strengths of the Turkish PPP model and ultimately offering her view on the state of the Turkish medical devices industry as a whole.   Turkey is an important…